17:22 EST ARS Pharmaceuticals (SPRY) files automatic mixed securities shelf
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRY:
- ARS Pharmaceuticals launches neffyinSchools program
- ARS Pharmaceuticals price target raised to $28 from $26 at Raymond James
- ARS Pharmaceuticals Highlights Success and Plans for 2025
- ARS Pharmaceuticals reports 2025 key strategic priorities
- ARS Pharmaceuticals reports preliminary Q4 neffy revenue $6.5M